Protagonist Therapeutics Inc buy BiotechBee
Start price
24.06.23
/
70%
€71.00
Target price
31.12.25
€40.00
Performance (%)
-
End price
31.08.23
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protagonist Therapeutics Inc | 4.255% | 4.255% | 237.156% |
| iShares Core DAX® | 0.336% | 4.366% | 21.868% |
| iShares Nasdaq 100 | 0.541% | 3.170% | 7.017% |
| iShares Nikkei 225® | 4.048% | 6.727% | 22.855% |
| iShares S&P 500 | 0.795% | 3.281% | 4.698% |
According to BiotechBee what are the pros and cons of Protagonist Therapeutics Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Buy mit Kursziel 40,0
In the thread Trading Protagonist Therapeutics Inc
Buy beendet

